People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biopharm Holding Corp. | — | Other | Series B | $28.6M | $475.0M | 2012 |
DANIEL H. EGELAND at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DANIEL H. EGELAND on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| WILLIAM H. JAMES | 1 | 5 |
| ANDREW T. COOK | 1 | 4 |
| A. Andrew Levinson | 1 | 3 |
| William J. Dyer | 1 | 3 |
| VINCENT H. TYRA | 1 | 2 |
| JEFFREY H. PERSINGER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.